Skip to main content

Day: March 16, 2026

NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI

NVIDIA Open Model Families for Agentic, Physical and Healthcare AINVIDIA announced new open source models, including Nemotron 3 Ultra, Omni and VoiceChat, Cosmos 3, Isaac GR00T N1.7, Alpamayo 1.5 and Proteina Complexa, to advance agentic, physical and healthcare AI.News Summary:NVIDIA Nemotron 3 omni-understanding models power AI agents delivering natural conversations, complex reasoning and advanced visual capabilities. NVIDIA Isaac GR00T N1.7, NVIDIA Alpamayo 1.5 and NVIDIA Cosmos 3 models push the boundaries of physical AI reasoning and action across robots and autonomous vehicles. Part of the NVIDIA BioNeMo platform, the Proteina-Complexa model accelerates protein drug discovery — alongside a new open dataset comprising millions of new, AI-predicted protein complex predictions, developed by NVIDIA, Google DeepMind, EMBL’s...

Continue reading

Comstock Inc. to Host Q4 2025 Earnings Call and Business Update

VIRGINIA CITY, Nev., March 16, 2026 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) is pleased to announce that the Company’s Executive Chairman & CEO, Corrado De Gasperis, and CFO, Judd Merrill will be providing an overview of our year-end financial results and current business updates on Tuesday, March 24, 2026, at 4:30pm ET. We invite all investors and other interested parties to register for the webinar at the link below. Date: Tuesday, March 24, 2026Time: 4:30pm ETRegister: Webinar Registration There will be an allotted time following the live presentation for a Q&A session. Unaddressed questions will be reviewed by management and responded to accordingly. You may submit your question(s) beforehand in the registration form (linked above) or by email at: ir@comstockinc.com. About Comstock...

Continue reading

Space Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about March 20, 2026

Princeton, NJ, March 16, 2026 (GLOBE NEWSWIRE) —  Space Asset Acquisition Corp. (Nasdaq: SAAQU) (the “Company”) today announced that holders of the units sold in the Company’s initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on January 29, 2026 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about March 20, 2026. Any units not separated will continue to trade on The Nasdaq Global Market under the symbol “SAAQU,” and each of the Class A ordinary shares and warrants will separately trade on The Nasdaq Global Market under the symbols “SAAQ” and “SAAQW,” respectively. No fractional warrants will be issued upon separation of the...

Continue reading

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) — HeartSciences Inc.  (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today reported financial results for its fiscal third quarter ended January 31, 2026 (“FQ3 2026”) and provided a business update. Third Quarter and Recent Highlights During the third quarter and subsequent period, the Company continued advancing the commercialization of its MyoVista Insights™ healthcare IT platform and submitted its MyoVista® wavECG™ device to the U.S. Food and Drug Administration (“FDA”) for 510(k) premarket clearance. MyoVista Insights™ Healthcare IT Software PlatformRegulatory classification....

Continue reading

Dragonfly Energy Announces Significant Corporate Actions and Reports Fourth Quarter and Full Year 2025 Preliminary Results

Full Year 2025 Revenue Increased 16% Driven By 34% Growth in OEM Sales Announces Reduction of Expenses, Improved Cost Structure and Accelerated Path to Profitability While Providing Greater Alignment with Shareholders Targets Positive Adjusted EBITDA at $70 Million Annual Revenue Run Rate Fourth Quarter and Full Year 2025 Financial HighlightsNet sales were $13.1 million and $58.6 million. OEM net sales were $8.1 million and $36.9 million. Gross Margin was 18.2% and 26.7%. Net Loss was $(45.0) million and $(69.9) million. Adjusted EBITDA was $(3.8) million and $(11.8) million.RENO, Nev., March 16, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and battery technology and maker of Battle Born Batteries®, today announced significant...

Continue reading

W&T Offshore Announces Final Fourth Quarter and Full Year 2025 Results, Including Year-End 2025 Proved Reserves and Provides Guidance for 2026

HOUSTON, March 16, 2026 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T,” the “Company,” “we” or “us”) today reported final operational and financial results for the fourth quarter and full year 2025, including the Company’s year-end 2025 reserve report. Detailed guidance for the first quarter of 2026 and full year 2026 was also provided. The Company issued Preliminary Estimated Financial Information for the Year Ended December 31, 2025 in a Form 8-K filed with the Securities and Exchange Commission on March 9, 2026. This press release includes non-GAAP financial measures, including Adjusted Net Loss, Adjusted EBITDA, Free Cash Flow, Net Debt and PV-10, which are described and reconciled to the most comparable GAAP measures in the accompanying tables to this press release under “Non-GAAP Information.” Key highlights...

Continue reading

Greystone Housing Impact Investors Reports Fourth Quarter 2025 Financial Results

OMAHA, Neb., March 16, 2026 (GLOBE NEWSWIRE) — On March 16, 2026, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months and year ended December 31, 2025. The Partnership also announced it will host a call on Thursday, March 19th at 4:30 p.m. Eastern Time to discuss the results and business outlook. Details for accessing the call can be found below under “Earnings Webcast & Conference Call.” Financial Highlights The Partnership reported the following results as of and for the three months ended December 31, 2025:Net loss of $2.6 million or $0.17 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $2.8 million or $0.12 per BUC Total assets of $1.5 billion Total Mortgage Revenue Bond (“MRB”) and Governmental...

Continue reading

Natural Gas Services Group, Inc. Reports Fourth Quarter and Full Year 2025 Financial and Operating Results; Provides 2026 Guidance

SOUTHLAKE, Texas, March 16, 2026 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the year and three months ended December 31, 2025. Fourth Quarter 2025 and Full Year 2025 HighlightsRental revenue of $44.3 million for the fourth quarter of 2025 represents a 16.0% year-over-year increase and a 6.8% sequential increase compared to the third quarter of 2025. Rental revenue for the full year 2025 of $164.3 million represents a 13.9% increase compared to 2024. Net income of $4.1 million, or $0.32 per diluted share, for the fourth quarter of 2025 compared to $2.9 million or $0.23 per diluted share for the fourth quarter of 2024. Net income for the full...

Continue reading

Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results

Lead program VMT-α-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reported at ASCO-GI 2026 VMT-α-NET study on track to achieve nearly one year of follow-up in all 46 patients in Cohort 2 by mid-2026; analysis to inform patient selection strategy ongoing Data across all dose levels in the VMT-α-NET program provide development optionality and support the build-out of a robust clinical evidence package for submission for presentation to more medical conferences and regulatory engagement in 2026 Clinical updates for all three clinical programs are expected to be submitted for presentation at medical conferences throughout 2026 Cash, cash equivalents and short-term investments of approximately $145M as of December...

Continue reading

Getty Images Reports Fourth Quarter and Full Year 2025 Results

Delivered full-year revenue of $981.3 million, well above upper end of guidance and the highest reported revenue in the Company’s 30-year history Full-year revenue growth of 4.5%, currency neutral growth of 3.8% Q4 revenue growth of 14.1%, currency neutral growth of 12.7% Shutterstock merger has obtained regulatory clearance without conditions in all jurisdictions except UK, where the CMA’s final report is due by June 14NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the fourth quarter and full year ended December 31, 2025. “In our 30th anniversary year we delivered record revenue, with growth across both Creative and Editorial,” said Craig Peters, Chief Executive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.